A comprehensive view of Diabetes. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

American Diabetes Assn. applauds New York’s move to eliminate cost-sharing for insulin in state-regulated health plans, marking a significant step towards medication affordability; nearly 12% of adult population in NY have been diagnosed with diabetes
Published: April 22, 2024 by American Diabetes Association
U.S. Patent and Trademark Office Releases Pfizer Inc's Patent Application for Pyrido[2,3-D]Imidazole Derivatives and Their Use as Inhibitors of ITK for the Treatment of Skin Disease
Published: April 22, 2024 by Pharmaceutical Patent News
Eli Lilly and Company Files Taiwan Patent Application for Long-Acting Amylin Receptor Agonists and Uses Thereof
Published: April 20, 2024 by Pharmaceutical Patent News
Eli Lilly and Company Submits Patent Application for Incretin Analog-Containing Compositions and Uses Thereof
Published: April 20, 2024 by Pharmaceutical Patent News
High demand for injectable weight-loss drugs has led to supply issues, with most varieties listed in short supply by the FDA; Eli Lilly reports shortages of its Zepbound and Mounjaro could last until 2025
Published: April 19, 2024 by CBS - 12 WJTV (Jackson, MS)

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count